Informaçao sobre o Autor

Krivorotko, P. V

Edição	Seção	Título	Arquivo
Nº 8 (2016)	Articles	NEOADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER
Nº 17 (2016)	Articles	TAXANES IN THE TREATMENT OF BREAST CANCER
Nº 17 (2017)	Articles	New possibilities of the treatment of breast cancer: microtubule inhibitors
Nº 7 (2018)	Articles	GONADOTROPIN-RELEASING HORMONE AGONISTS-INDUCED OVARIAN SUPPRESSION IN EARLY BREAST CANCER
Nº 12 (2018)	Articles	Ways to improve efficiency of endocrino-therapy of breast cancer: new targeted cells, new therapeutic opportunities
Volume 27, Nº 7 (2020)	Articles	Alpelisib for the treatment of HR+HER2-metastatic breast cancer in patients with the PIK3CA mutation: results of the SOLAR-1 study
Volume 27, Nº 7 (2020)	Articles	Treatment of residual breast cancer
Volume 27, Nº 7 (2020)	Articles	Abemacyclib - new options for the treatment of hormone-positive metastatic breast cancer with CDK4/6 inhibitors
Volume 29, Nº 7 (2022)	Articles	Clinical immunology of breast cancer
Volume 29, Nº 7 (2022)	Articles	Predictive and prognostic role of tumor-infiltrating lymphocytes (TILs) in early triple-negative breast cancer
Volume 29, Nº 7 (2022)	Articles	Treatment of HER2-positive early (minimal) breast cancer
Volume 29, Nº 11/12 (2022)	Articles	The role of alpelisib in the treatment of PIK3CA - a mutated breast cancer
Volume 29, Nº 11/12 (2022)	Articles	Ixabepilone in the treatment of breast cancer